-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : TRUIST SECURITIES CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $225 FROM $315

Reuters·11/02/2026 12:06:39

Please log in to view news